Le Beau Visage Medical Spa Frisco Now Offering Dysport, Botox Alternative
7/27/2009 9:22:00 AM
FDA Approves Dysport, a Botox Competitor - Physicians and patients now have a choice when selecting botulinum toxin type A to smooth out wrinkles with the recently FDA-approved Dysport, a wrinkle treatment and alternative to Botox. Le Beau Visage will now offer both treatments to better serve our patients.
 Frisco, TX, July 25, 2009 --(PR.com)-- The wrinkle treatment, Dysport, is now available at Le Beau Visage Medical Spa. In April 2009 The U. S. Food and Drug Administration (FDA) approved Dysport™ for the treatment of wrinkles and frown lines. This is one of the most anticipated introductions of a product in the field of aesthetic medicine in years.
The approval includes two separate indications. One is for the treatment of cervical dystonia in adults to reduce the severity of abnormal head position and neck pain, and the other indication is for the temporary improvement in the appearance of moderate to severe glabellar lines in adults younger than 65 years of age. Both botulinum toxin products, Botox® and Dysport™, help reduce wrinkles by relaxing overactive muscles but they are not interchangeable formulations. "While the action Dysport™® and Botox® Cosmetic are similar, they are distinctly different drugs," says Dr. Jason M. Riehs, Medical Director of Le Beau Visage Medical Spa. "There are distinct dosing differences and, although both are measured in units, the number of units injected is not comparable when treating the same areas to get the similar result.” There are other differences in the botulinum toxins as well. Dysport™ seems to have a faster onset and has a greater “field” while Botox® tends to remain more localized, allowing for greater precision in the treated area. “Having more products to choose from is beneficial for our patients because it enables physicians to select the best treatment for each patient’s needs,” says Dr. Riehs. About DYSPORT™ (abobotulinumtoxinA)
The active substance in DYSPORT™ is a botulinum neurotoxin type A complex, which acts at the level of the neuromuscular junction in the targeted muscle. DYSPORT™ is a neuromuscular blocking toxin which acts to block acetylcholine release at motor nerve ends and reduces muscular contraction. Dysport™ has been available in Europe, Asia, and South America for over 10 years. Dysport™ is distributed in the United States by Medicis, the manufacturers of injectable fillers Restylane® and Perlane®. Dysport™ was developed in the United Kingdom in the early 1990s to successfully treat a number of neurological and ophthalmic conditions. Its use was further expanded to treat a wide variety of neuromuscular disorders, for which it is licensed in over 60 countries. About the U.S. Aesthetic Market
According to the American Society for Aesthetic Plastic Surgery, over 10 million cosmetic procedures were performed in the U.S. in 2008, 83% of which represented nonsurgical procedures. Injections of botulinum toxin type A have been the number one nonsurgical cosmetic procedure for the past five years, with over 2.4 million total procedures in 2008 alone. The current U.S. aesthetic market for botulinum toxin type A is estimated to be approximately $300 million to $400 million. About Le Beau Visage
Dr. Jason Riehs and his personally trained staff welcome you to visit Le Beau Visage aesthetic center. Here at Le Beau Visage, your safety is our first priority and our goal is to provide each patient with individualized, state-of-the art care in cosmetic medicine. We apply our skill with kindness and artisty in an environment that provides an exhilarating experience for the patient. Our office takes pride in working hard to maintain the toughest standard in choosing the latest techniques in cosmetic surgery for your safety and best cosmetic results. Dr. Jason M. Riehs’ practice includes many diverse areas of specialization including, Cosmetic (Aesthetic) Injectables and Skin Care. Dr. Riehs and his staff are dedicated to providing service and satisfaction at such a high level, that our patients refer their closest friends and family.
Related articles:
Le Beau Visage Medical Spa Frisco Now Offering Dysport, Botox Alternative - FDA Approves Dysport, a Botox Competitor - Physicians and patients now have a choice when selecting botulinum toxin type A to smooth out wrinkles with the recently FDA-approved Dysport, a wrinkle treatment and alternative to Botox. Le Beau Visage will now offer both treatments to better serve our patients.
|
Featured Dysport Providers
Michael S. Escobedo, MD
2312 Western Trails, Suite 103
Austin
Dysport
Serena MedSpa
Preston Center
8455 Kate Street
Dallas
Dysport
Kevin Light, DO, MBA
Texas Institute of Functional Medicines
4001 McEwen Road, Suite 102
Dallas
Dysport
|
